4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001638599-21-000590
Options or other derivatives
- Director acquired 23,344 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP Director | 2021-06-18 | Grant or award · Non-Qualified Stock Options (right to buy) | +23,344 | 23,344 | I: show line 1 in the form |
Loading xslF345X03/doc4_7283.xml…